FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2547846168> ?p ?o ?g. }

• W2547846168 endingPage "166" @default.
• W2547846168 startingPage "160" @default.
• W2547846168 abstract "A few recent studies investigated the prognostic impact of CD30 expression in diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone. No study has evaluated the significance of CD30 expression in DLBCL patients treated with rituximab, etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (R-EPOCH). In a group of 97 patients with DLBCL and high-risk features who received R-EPOCH induction therapy, we studied CD30 expression by immunohistochemistry using different cutoff values (>0% and ≥20% of lymphoma cells, respectively) and correlated with prognosis. CD30 expression was detected in 24 (25%) cases using a cutoff greater than 0% and in 12 (12%) cases using a cutoff of 20% or greater. The clinicopathological features were similar between CD30+ and CD30-negative groups. A major difference was that MYC rearrangement was infrequent in the CD30+ group: 2 (9%) of 23 in CD30+ versus 25 (35%) of 72 in CD30-negative group (P = .02). CD30 expression was not associated with germinal center B-cell–like (GCB) or non-GCB type. Overall survival (OS) was not significantly different between patients with CD30+ and patients with CD30-negative DLBCL, either for all patients or for the subset of patients without MYC rearrangement, regardless of cutoff (P > .05). CD30 expression was not associated with OS in either GCB or non-GCB subtype (P > .05, > 0% cutoff). In conclusion, CD30 expression was detected in up to 25% of cases of DLBCL and was more frequent in tumors without MYC rearrangement. CD30 expression was not associated with OS in R-EPOCH–treated de novo DLBCL patients." @default.
• W2547846168 created "2016-11-11" @default.
• W2547846168 creator A5000027373 @default.
• W2547846168 creator A5001368828 @default.
• W2547846168 creator A5006583715 @default.
• W2547846168 creator A5019724584 @default.
• W2547846168 creator A5025198232 @default.
• W2547846168 creator A5037784199 @default.
• W2547846168 creator A5038345056 @default.
• W2547846168 creator A5046180000 @default.
• W2547846168 creator A5055404021 @default.
• W2547846168 creator A5075523270 @default.
• W2547846168 creator A5090832029 @default.
• W2547846168 date "2017-02-01" @default.
• W2547846168 modified "2023-09-30" @default.
• W2547846168 title "CD30 expression and prognostic significance in R-EPOCH–treated patients with diffuse large B-cell lymphoma" @default.
• W2547846168 cites W1001409994 @default.
• W2547846168 cites W1934324164 @default.
• W2547846168 cites W1965824265 @default.
• W2547846168 cites W2011118089 @default.
• W2547846168 cites W2018071905 @default.
• W2547846168 cites W2024972915 @default.
• W2547846168 cites W2028850684 @default.
• W2547846168 cites W2029473952 @default.
• W2547846168 cites W2034881106 @default.
• W2547846168 cites W2037524923 @default.
• W2547846168 cites W2037904581 @default.
• W2547846168 cites W2045417135 @default.
• W2547846168 cites W2060466778 @default.
• W2547846168 cites W2075864830 @default.
• W2547846168 cites W2085561179 @default.
• W2547846168 cites W2087945287 @default.
• W2547846168 cites W2095064018 @default.
• W2547846168 cites W2101212351 @default.
• W2547846168 cites W2125523937 @default.
• W2547846168 cites W2130305562 @default.
• W2547846168 cites W2139891818 @default.
• W2547846168 cites W2145304413 @default.
• W2547846168 cites W2145947729 @default.
• W2547846168 cites W2158267770 @default.
• W2547846168 cites W2159862107 @default.
• W2547846168 cites W2473984749 @default.
• W2547846168 doi "https://doi.org/10.1016/j.humpath.2016.10.009" @default.
• W2547846168 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27816715" @default.
• W2547846168 hasPublicationYear "2017" @default.
• W2547846168 type Work @default.
• W2547846168 sameAs 2547846168 @default.
• W2547846168 citedByCount "10" @default.
• W2547846168 countsByYear W25478461682018 @default.
• W2547846168 countsByYear W25478461682019 @default.
• W2547846168 countsByYear W25478461682020 @default.
• W2547846168 countsByYear W25478461682021 @default.
• W2547846168 countsByYear W25478461682022 @default.
• W2547846168 countsByYear W25478461682023 @default.
• W2547846168 crossrefType "journal-article" @default.
• W2547846168 hasAuthorship W2547846168A5000027373 @default.
• W2547846168 hasAuthorship W2547846168A5001368828 @default.
• W2547846168 hasAuthorship W2547846168A5006583715 @default.
• W2547846168 hasAuthorship W2547846168A5019724584 @default.
• W2547846168 hasAuthorship W2547846168A5025198232 @default.
• W2547846168 hasAuthorship W2547846168A5037784199 @default.
• W2547846168 hasAuthorship W2547846168A5038345056 @default.
• W2547846168 hasAuthorship W2547846168A5046180000 @default.
• W2547846168 hasAuthorship W2547846168A5055404021 @default.
• W2547846168 hasAuthorship W2547846168A5075523270 @default.
• W2547846168 hasAuthorship W2547846168A5090832029 @default.
• W2547846168 hasConcept C126322002 @default.
• W2547846168 hasConcept C142724271 @default.
• W2547846168 hasConcept C143998085 @default.
• W2547846168 hasConcept C204232928 @default.
• W2547846168 hasConcept C2776694085 @default.
• W2547846168 hasConcept C2776755627 @default.
• W2547846168 hasConcept C2778559949 @default.
• W2547846168 hasConcept C2778720950 @default.
• W2547846168 hasConcept C2779338263 @default.
• W2547846168 hasConcept C2779429289 @default.
• W2547846168 hasConcept C2780653079 @default.
• W2547846168 hasConcept C70905583 @default.
• W2547846168 hasConcept C71924100 @default.
• W2547846168 hasConceptScore W2547846168C126322002 @default.
• W2547846168 hasConceptScore W2547846168C142724271 @default.
• W2547846168 hasConceptScore W2547846168C143998085 @default.
• W2547846168 hasConceptScore W2547846168C204232928 @default.
• W2547846168 hasConceptScore W2547846168C2776694085 @default.
• W2547846168 hasConceptScore W2547846168C2776755627 @default.
• W2547846168 hasConceptScore W2547846168C2778559949 @default.
• W2547846168 hasConceptScore W2547846168C2778720950 @default.
• W2547846168 hasConceptScore W2547846168C2779338263 @default.
• W2547846168 hasConceptScore W2547846168C2779429289 @default.
• W2547846168 hasConceptScore W2547846168C2780653079 @default.
• W2547846168 hasConceptScore W2547846168C70905583 @default.
• W2547846168 hasConceptScore W2547846168C71924100 @default.
• W2547846168 hasLocation W25478461681 @default.
• W2547846168 hasLocation W25478461682 @default.
• W2547846168 hasOpenAccess W2547846168 @default.
• W2547846168 hasPrimaryLocation W25478461681 @default.
• W2547846168 hasRelatedWork W2023162095 @default.
• W2547846168 hasRelatedWork W2132500976 @default.

• next